HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Host immunosurveillance controls tumor growth via IFN regulatory factor-8 dependent mechanisms.

Abstract
IFN regulatory factor (IRF)-8 plays an important role in normal myelopoiesis. The loss of IRF-8 in myeloid cells results in a chronic myelogenous leukemia-like syndrome, suggesting that IRF-8 behaves as a tumor suppressor gene in certain hematopoietic malignancies. We have been investigating the molecular determinants of solid tumor progression, with an emphasis on apoptotic resistance. Recently, we showed that IRF-8 expression was directly correlated with Fas-mediated apoptosis, and inversely related to malignant phenotype. However, the functional role of IRF-8 in solid tumors is unresolved. We stably silenced IRF-8 expression via RNA interference in IRF-8-expressing mouse tumor cells, and evaluated them for changes in apoptotic phenotype and malignant behavior. Apoptosis induced by Fas engagement or irradiation was markedly reduced in IRF-8-deficient tumor cells, despite unaltered proliferation, cell surface Fas, or MHC class I expression. Moreover, in syngeneic immunocompetent mice, IRF-8-deficient tumor cells grew more aggressively than their control counterparts. However, in IFN-gamma- or Fas ligand-deficient mice, but not T cell-deficient mice, both control and IRF-8-deficient tumor populations grew similarly. Furthermore, both tumor populations grew similarly in mice with defects in innate immunity. Although subsequent studies precluded a role for natural killer cells, immunohistochemical analysis supported the involvement of macrophages. Overall, our findings show that IRF-8 expression in solid tumor cells is important for efficient host immunosurveillance and response to apoptotic stimuli. Therefore, IRF-8 down-regulation may represent a previously unrecognized tumor escape mechanism that facilitates tumor progression. Conversely, strategies aimed at up-regulating or restoring IRF-8 expression in neoplastic cells may improve therapeutic efficacy.
AuthorsKristy M Greeneltch, Monika Schneider, Seth M Steinberg, David J Liewehr, Trina J Stewart, Kebin Liu, Scott I Abrams
JournalCancer research (Cancer Res) Vol. 67 Issue 21 Pg. 10406-16 (Nov 01 2007) ISSN: 1538-7445 [Electronic] United States
PMID17974984 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Fas Ligand Protein
  • Interferon Regulatory Factors
  • fas Receptor
  • interferon regulatory factor-8
  • Interferon-gamma
Topics
  • Animals
  • Apoptosis
  • Cell Line, Tumor
  • Cell Proliferation
  • Fas Ligand Protein (physiology)
  • Female
  • Immunity, Innate
  • Interferon Regulatory Factors (antagonists & inhibitors, genetics, physiology)
  • Interferon-gamma (physiology)
  • Killer Cells, Natural (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Neoplasms, Experimental (immunology, pathology)
  • Tumor Escape
  • fas Receptor (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: